Clinical Trials Browser

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT00412217 2016-11-25

A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer

Phase 3 Terminated

94 enrolled 6 charts

Head & Neck

Head and Neck Neoplasms

NCT00355355 2015-01-30

A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)

Phase 3 Completed

208 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00574860 2013-09-20

EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer

Phase 3 Terminated

240 enrolled

Head & Neck

Head and Neck Neoplasms, Stomatitis

Clinical Trials

MK-3475-587

Orca-T

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

AcTFirst

The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

FIRST

Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients

EMERALD

TRANSFORM

ASTEROID 6

Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain

INTACT

(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive

EAGLE

Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer

Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder

A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer

A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)

EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer